GALIMI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.858
EU - Europa 1.342
AS - Asia 1.144
SA - Sud America 47
OC - Oceania 20
AF - Africa 13
Totale 5.424
Nazione #
US - Stati Uniti d'America 2.805
CN - Cina 595
IT - Italia 436
SG - Singapore 229
DE - Germania 179
IE - Irlanda 114
GB - Regno Unito 104
JP - Giappone 82
SE - Svezia 74
FI - Finlandia 69
AT - Austria 62
FR - Francia 58
IN - India 46
HK - Hong Kong 44
UA - Ucraina 44
CA - Canada 43
BR - Brasile 41
KR - Corea 40
PL - Polonia 39
NL - Olanda 32
ES - Italia 25
VN - Vietnam 21
BE - Belgio 20
AU - Australia 18
ID - Indonesia 18
RU - Federazione Russa 18
TW - Taiwan 17
CH - Svizzera 15
TR - Turchia 13
IR - Iran 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
RO - Romania 8
TH - Thailandia 8
MX - Messico 7
NO - Norvegia 6
GR - Grecia 5
UZ - Uzbekistan 5
CO - Colombia 3
EE - Estonia 3
HU - Ungheria 3
IL - Israele 3
LK - Sri Lanka 3
SI - Slovenia 3
ZA - Sudafrica 3
BD - Bangladesh 2
DM - Dominica 2
EG - Egitto 2
KZ - Kazakistan 2
MA - Marocco 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GH - Ghana 1
IM - Isola di Man 1
KE - Kenya 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 5.424
Città #
Ann Arbor 509
Chandler 283
Fairfield 261
Beijing 153
Singapore 141
Ashburn 137
Seattle 118
Woodbridge 116
Houston 102
Dublin 98
Wilmington 88
Cambridge 87
Torino 83
Shanghai 76
Santa Clara 52
Vienna 52
Pisa 48
Dearborn 41
Nyköping 36
Redwood City 35
Tokyo 35
Turin 34
Milan 33
Warsaw 30
Los Angeles 29
New York 29
Jacksonville 28
Guangzhou 26
Princeton 26
Villeurbanne 24
Columbus 23
The Dalles 23
Medford 22
Nanjing 21
Helsinki 20
Naples 20
Boardman 18
Brussels 18
San Diego 18
Hong Kong 17
Jakarta 16
Taipei 16
Changsha 15
Manchester 15
Ottawa 15
Chicago 14
Fremont 14
Lappeenranta 14
London 14
Wuhan 14
Boston 13
Hangzhou 13
Genoa 12
Munich 12
Paris 12
Toronto 12
Chengdu 11
Dong Ket 11
Nanchang 11
Nuremberg 11
Luni 10
Rome 10
Seoul 10
Shenyang 10
Amsterdam 9
Chongqing 9
Berlin 8
Moscow 8
Salt Lake City 8
Austin 7
Barcelona 7
Bethesda 7
Duncan 7
Fuzhou 7
Pittsburgh 7
Zhengzhou 7
Buffalo 6
Central 6
Düsseldorf 6
Eitensheim 6
Galway 6
Heidelberg 6
Kocaeli 6
Nashville 6
Shenzhen 6
Silver Spring 6
Zurich 6
Bangkok 5
Birmingham 5
Bochum 5
Bologna 5
Changchun 5
Gurgaon 5
Jinan 5
Madison 5
Melbourne 5
Brookline 4
Chatsworth 4
Delhi 4
Falls Church 4
Totale 3.533
Nome #
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 763
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 747
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 352
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 341
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 335
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 299
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3. 271
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 268
Only a subset of Met-activated pathways are required to sustain oncogene addiction 265
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 262
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 261
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 242
Inhibition of Src impairs the growth of met-addicted gastric tumors. 231
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 205
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 187
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 99
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 92
Met as a potential therapeutic target in basal-like breast cancer 84
Signaling response to transient redox stress in human isolated T cells: Molecular sensor role of syk kinase and functional involvement of IL2 receptor and L-selectine 84
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 83
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients 50
Totale 5.521
Categoria #
all - tutte 12.836
article - articoli 0
book - libri 0
conference - conferenze 1.627
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 0 0 0 0 49 42 34
2020/2021603 34 50 58 38 32 47 69 38 45 63 32 97
2021/20221.006 110 90 72 98 62 59 87 71 52 62 149 94
2022/2023736 73 77 31 78 52 149 41 64 70 16 44 41
2023/2024563 56 54 35 46 38 51 33 66 16 54 78 36
2024/2025769 26 35 98 71 145 95 43 73 105 78 0 0
Totale 5.521